$8.46
-0.28-3.20%
Last update: Jul 12, 6:27 AM
15 minutes delayed
Talis Biomedical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Talis Biomedical using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TLIS | Talis Biomedical | -$8.27 | — | — | — | $581.00K | — | — | — | 08/08/2024 | Get Alert |
TLIS | Talis Biomedical | -$9.84 | — | -$7.15 | — | $1.22M | — | $73.00K | — | 05/08/2024 | Get Alert |
TLIS | Talis Biomedical | -$15.15 | — | -$7.39 | — | $257.00K | — | $195.00K | — | 03/28/2024 | Get Alert |
TLIS | Talis Biomedical | -$14.70 | -$7.37 | -$8.62 | -16.96% | $796.00K | $100.00K | $140.00K | 40.00% | 11/14/2023 | Get Alert |
TLIS | Talis Biomedical | -$15.15 | -$8.25 | -$8.27 | -0.24% | $572.00K | — | $581.00K | — | 08/10/2023 | Get Alert |
TLIS | Talis Biomedical | -$18.75 | -$10.95 | -$9.90 | 9.59% | $3.19M | $250.00K | $1.22M | 387.20% | 05/11/2023 | Get Alert |
TLIS | Talis Biomedical | -$1.05 | -$10.20 | -$15.15 | -48.53% | $858.00K | $800.00K | $257.00K | -67.87% | 03/22/2023 | Get Alert |
TLIS | Talis Biomedical | -$22.35 | -$10.95 | -$14.70 | -34.25% | $218.00K | $600.00K | $796.00K | 32.67% | 11/03/2022 | Get Alert |
TLIS | Talis Biomedical | -$37.65 | -$12.00 | -$15.15 | -26.25% | $117.00K | $700.00K | $572.00K | -18.29% | 08/02/2022 | Get Alert |
TLIS | Talis Biomedical | -$69.15 | -$17.70 | -$18.75 | -5.93% | $7.00M | $650.00K | $3.19M | 390.31% | 05/10/2022 | Get Alert |
TLIS | Talis Biomedical | — | -$19.20 | -$1.05 | 94.53% | — | $1.33M | $858.00K | -35.49% | 03/15/2022 | Get Alert |
TLIS | Talis Biomedical | -$208.50 | -$21.00 | -$22.35 | -6.43% | $9.49M | $1.46M | $218.00K | -85.07% | 11/15/2021 | Get Alert |
TLIS | Talis Biomedical | -$71.25 | -$13.65 | -$37.65 | -175.82% | $820.00K | — | $117.00K | — | 08/10/2021 | Get Alert |
TLIS | Talis Biomedical | — | -$162.00 | -$69.15 | 57.31% | — | $230.00K | $7.00M | 2943.48% | 05/11/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-14 | $-8.62 | $-7.37 | -17.0 % |
Jun 2023 | 2023-08-10 | $-8.27 | $-8.25 | -0.24 % |
Mar 2023 | 2023-05-11 | $-9.90 | $-10.95 | 9.59 % |
Dec 2022 | 2023-03-22 | $-15.15 | $-10.20 | -48.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-14 | $140.00K | $100.00K | 40.0 % |
Mar 2023 | 2023-05-11 | $1.22M | $250.00K | 387.2 % |
Dec 2022 | 2023-03-22 | $257.00K | $800.00K | -67.9 % |
Sep 2022 | 2022-11-03 | $796.00K | $600.00K | 32.7 % |
Talis Biomedical (TLIS) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
The Actual EPS was $-7.15, which missed the estimate of $0.00.
The Actual Revenue was $73K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.